Rifaximin description: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Rifaximin}} {{CMG}}; {{AE}} {{chetan}} http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1 ==References== {{Reflist}} ..." |
No edit summary |
||
| Line 5: | Line 5: | ||
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | publisher = | date = | accessdate = }}</ref> | |||
Revision as of 20:55, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
References
Adapted from the FDA Package Insert.